Related Experiment Video
Updated: Jun 18, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Trials with impact on clinical management: first line
1Arizona Cancer Center, 1515 N Campbell Avenue, Tucson, AZ 85724-5024, USA. mbookman@azcc.arizona.edu
Summary
Standard chemotherapy for advanced ovarian cancer using carboplatin and paclitaxel is effective. Weekly paclitaxel dosing may offer superior outcomes compared to standard schedules, with ongoing research into new treatments.
Area of Science:
- Gynecologic Oncology
- Medical Oncology
- Translational Cancer Research
Background:
- Advanced-stage epithelial ovarian cancer treatment relies on surgery and carboplatin/paclitaxel chemotherapy.
- Tumors often develop resistance to chemotherapy, leading to recurrence.
- Phase 3 trials have advanced understanding but require interpretation within evolving biological and clinical contexts.
Purpose of the Study:
- To review current evidence from phase 3 trials in ovarian cancer.
- To interpret findings within the context of emerging ovarian tumor biology.
- To inform optimal treatment strategies for ovarian cancer.
Main Methods:
- Systematic review of recent phase 3 clinical trials.
- Analysis of current principles in ovarian tumor biology.
Main Results:
- Adding a third cytotoxic agent to carboplatin and paclitaxel does not improve outcomes.
- Weekly dose-dense paclitaxel scheduling demonstrates superiority over standard dosing.
Conclusions:
- Carboplatin and paclitaxel remain a well-tolerated standard regimen for primary ovarian cancer therapy.
- Weekly paclitaxel dosing is a viable alternative.
- Future individualized treatments will be informed by ongoing trials and new biological insights.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...